Group Leader. Developmental and Comparative Genomics, Transcriptional Regulation, Skeletal and Limb Development, Tissue Engineering, Sclerosteosis and Van Buchem Disease, Genetics of Osteoporosis and Osteoarthritis, Pharmacogenomics, Cancer Metastasis |
|
Radiobiology, molecular biology, biochemistry, and biodetection. |
|
Toxicology, imaging, drug delivery/therapy, nanoparticles. |
|
Nanolipoprotein particles as an in vivo delivery platform for biomedical applications; strategies for streamlining the development and optimization of oligonuceotide aptamers. |
|
Toxicology, Pharmacology, Biochemistry, Biomedical applications of accelerator mass spectrometry. |
|
Molecular Biology, Skeletal and Limb Development, Genetics of Osteoporosis and Osteoarthritis |
|
Analytical biochemistry, chromatography, mass spectrometry, quantitative metabolism. |
|
Molecular Biology, Skeletal and Limb Development, Genetics of Osteoporosis and Osteoarthritis |
|
Molecular Biology, Radiobiology, and Biodetection |